We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$886M
AUM Growth
-$133M
Cap. Flow
-$156M
Cap. Flow %
-17.57%
Top 10 Hldgs %
96.5%
Holding
34
New
1
Increased
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
CART icon
Maplebear
CART
+$15.8M

Sector Composition

Rank Sector Weight
1 Communication Services 58.17%
2 Consumer Discretionary 23.31%
3 Technology 13.87%
4 Healthcare 2.34%
5 Industrials 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.51T
$288M 32.48%
958,505
-177,411
-16% -$53.5M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.91T
$228M 25.69%
1,738,875
-672,665
-28% -$87M
LNW
3
DELISTED
Light & Wonder
LNW
$191M 21.57%
2,678,571
GRAB icon
4
Grab
GRAB
$13.5B
$46.1M 5.21%
13,036,482
NVDA icon
5
NVIDIA
NVDA
$5.01T
$21.9M 2.47%
502,890
TSM icon
6
TSMC
TSM
$2.09T
$17.6M 1.99%
202,347
AMD icon
7
Advanced Micro Devices
AMD
$851B
$17.2M 1.94%
167,406
ASML icon
8
ASML
ASML
$675B
$16.2M 1.83%
27,519
CART icon
9
Maplebear
CART
$9.92B
$15.4M 1.74%
+519,838
New +$15.8M
PCTTW
10
PureCycle Technologies Inc Warrant
PCTTW
$9.5M
$14M 1.58%
2,498,170
TNGX icon
11
Tango Therapeutics
TNGX
$4.34B
$7.98M 0.9%
708,385
TXG icon
12
10x Genomics
TXG
$5.87B
$7.01M 0.79%
170,000
-16,143
-9% -$840K
RKLB icon
13
Rocket Lab Corp
RKLB
$39.9B
$4.38M 0.49%
1,000,000
CFLT
14
DELISTED
Confluent
CFLT
$3.86M 0.44%
130,383
TNYA icon
15
Tenaya Therapeutics
TNYA
$168M
$1.72M 0.19%
673,270
VIGL
16
DELISTED
Vigil Neuroscience
VIGL
$1.56M 0.18%
289,460
PCT icon
17
PureCycle Technologies
PCT
$1.17B
$1.19M 0.13%
714,285
KITT icon
18
Nauticus Robotics
KITT
$5.27M
$885K 0.1%
193
XLO icon
19
Xilio Therapeutics
XLO
$56.9M
$878K 0.1%
29,719
SANA icon
20
Sana Biotechnology
SANA
$885M
$837K 0.09%
216,376
-252,373
-54% -$1.36M
SRZN icon
21
Surrozen
SRZN
$229M
$405K 0.05%
55,123
MCRB icon
22
Seres Therapeutics
MCRB
$48M
$314K 0.04%
6,592
DNTH icon
23
Dianthus Therapeutics
DNTH
$5.68B
-20,788
Closed -$252K
FULC icon
24
Fulcrum Therapeutics
FULC
$248M
-341,972
Closed -$1.13M
GBIO
25
DELISTED
Generation Bio
GBIO
-51,035
Closed -$2.81M

Similar funds

Harvard Management Company's Q3 2023 Portfolio in Review

As of Q3 2023, Harvard Management Company held 34 positions worth $886M, down 13% from $1.02B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Harvard Management Company withdrew a net $156M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was EQRx, Inc. Common Stock, an estimated $7.17M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 58% of assets, down from 60% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Harvard Management Company opened a new position in Maplebear worth $15.4M.

  • Harvard Management Company's largest Q3 2023 buy was Maplebear: 519,838 shares worth $15.4M.
  • Harvard Management Company's biggest Q3 2023 reduction was Alphabet (Google) Class A, cutting an estimated $87M.
  • Harvard Management Company fully exited EQRx, Inc. Common Stock in Q3 2023, selling an estimated $7.17M.
  • Harvard Management Company's ten largest holdings make up 96% of its $886M portfolio in Q3 2023.
  • Harvard Management Company opened 1 new position and closed 12 in Q3 2023.
  • Harvard Management Company's portfolio value fell 13% quarter-over-quarter to $886M.

Based on Harvard Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.